Genetic engineering of human pluripotent cells using TALE nucleases
Targeted genetic engineering of human pluripotent cells is a prerequisite for exploiting their
full potential. Such genetic manipulations can be achieved using site-specific nucleases. …
full potential. Such genetic manipulations can be achieved using site-specific nucleases. …
Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases
D Hockemeyer, F Soldner, C Beard, Q Gao… - Nature …, 2009 - nature.com
Realizing the full potential of human embryonic stem cells (hESCs) and induced pluripotent
stem cells (hiPSCs) requires efficient methods for genetic modification. However, techniques …
stem cells (hiPSCs) requires efficient methods for genetic modification. However, techniques …
POT1 protects telomeres from a transient DNA damage response and determines how human chromosomes end
The hallmarks of telomere dysfunction in mammals are reduced telomeric 3′ overhangs,
telomere fusions, and cell cycle arrest due to a DNA damage response. Here, we report on the …
telomere fusions, and cell cycle arrest due to a DNA damage response. Here, we report on the …
[HTML][HTML] Mammalian telomeres resemble fragile sites and require TRF1 for efficient replication
A Sfeir, ST Kosiyatrakul, D Hockemeyer, SL MacRae… - Cell, 2009 - cell.com
Telomeres protect chromosome ends through the interaction of telomeric repeats with shelterin,
a protein complex that represses DNA damage signaling and DNA repair reactions. The …
a protein complex that represses DNA damage signaling and DNA repair reactions. The …
Myocardin and ternary complex factors compete for SRF to control smooth muscle gene expression
Smooth muscle cells switch between differentiated and proliferative phenotypes in response
to extracellular cues 1 , but the transcriptional mechanisms that confer such phenotypic …
to extracellular cues 1 , but the transcriptional mechanisms that confer such phenotypic …
Mutations in the promoter of the telomerase gene TERT contribute to tumorigenesis by a two-step mechanism
…, A Oh, J Ryu, X Darzacq, BC Bastian, D Hockemeyer - Science, 2017 - science.org
TERT promoter mutations (TPMs) are the most common noncoding mutations in cancer.
The timing and consequences of TPMs have not been fully established. Here, we show that …
The timing and consequences of TPMs have not been fully established. Here, we show that …
[HTML][HTML] Recent expansion of the telomeric complex in rodents: Two distinct POT1 proteins protect mouse telomeres
D Hockemeyer, JP Daniels, H Takai, T de Lange - Cell, 2006 - cell.com
Human telomeres are protected by shelterin, a complex that includes the POT1 single-stranded
DNA binding protein. We found that mouse telomeres contain two POT1 paralogs, …
DNA binding protein. We found that mouse telomeres contain two POT1 paralogs, …
[PDF][PDF] Induced pluripotent stem cells meet genome editing
D Hockemeyer, R Jaenisch - Cell stem cell, 2016 - cell.com
It is extremely rare for a single experiment to be so impactful and timely that it shapes and
forecasts the experiments of the next decade. Here, we review how two such experiments—the …
forecasts the experiments of the next decade. Here, we review how two such experiments—the …
Observing the cell in its native state: Imaging subcellular dynamics in multicellular organisms
…, H Yashiro, S Scholpp, EM Meyerowitz, D Hockemeyer… - Science, 2018 - science.org
INTRODUCTION Organisms live by means of the complex, dynamic, three-dimensional (3D)
interplay between millions of components, from the molecular to the multicellular. …
interplay between millions of components, from the molecular to the multicellular. …
[HTML][HTML] Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors
F Soldner, D Hockemeyer, C Beard, Q Gao, GW Bell… - Cell, 2009 - cell.com
Induced pluripotent stem cells (iPSCs) derived from somatic cells of patients represent a
powerful tool for biomedical research and may provide a source for replacement therapies. …
powerful tool for biomedical research and may provide a source for replacement therapies. …